Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

19.05
-0.4300-2.21%
Post-market: 19.050.00000.00%19:30 EDT
Volume:496.60K
Turnover:9.48M
Market Cap:848.90M
PE:-11.55
High:19.54
Open:19.50
Low:18.54
Close:19.48
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:24.29M
Volume Ratio:0.31
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.31
PE(LYR):-10.52

Loading ...

Company Profile

Company Name:
Beta Bionics, Inc.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
422
Office Location:
11 Hughes,Irvine,California,United States
Zip Code:
92618
Fax:
- -
Introduction:
Beta Bionics, Inc. was incorporated in October 2015 as a Massachusetts public benefit corporation and converted to a Delaware corporation in August 2024. The company is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions that improve the health and quality of life of people with insulin-requiring diabetes by leveraging advanced adaptive closed-loop algorithms to simplify and enhance disease management.

Directors

Name
Position
Sean Saint
Chief Executive Officer and Director
Adam Lezack
Chairperson
Christy Jones
Director
Dan Dearen
Director
Maria Palasis
Director
Sean Carney
Director

Shareholders

Name
Position
Sean Saint
Chief Executive Officer and Director
Stephen Feider
Chief Financial Officer
Mark Hopman
Chief Commercial Officer
Mike Mensinger
Chief Product Officer
Steven Russell
Chief Medical Officer